Need help finding what you are looking for?
Contact Us
PUBLISHER: Visiongain | PRODUCT CODE: 1809418
PUBLISHER: Visiongain | PRODUCT CODE: 1809418
Biopharmaceuticals Contract Manufacturing Market Report 2025-2035
PUBLISHED:
PAGES: 393 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global Biopharmaceuticals Contract Manufacturing market is projected to grow at a CAGR of 11.6% by 2035.
The Biopharmaceuticals Contract Manufacturing Market Report 2025-2035 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Biopharmaceutical contract manufacturing has become a critical enabler for companies navigating the complexity of biologics and advanced therapies. With rising demand for monoclonal antibodies, cell therapies, and gene therapies, outsourcing provides biopharma innovators with access to scalable, regulatory-compliant infrastructure while allowing them to concentrate resources on discovery and development. Contract manufacturing organisations (CMOs) play a pivotal role in reducing time-to-market, optimising costs, and offering technical expertise that many firms cannot replicate in-house.
The sector is experiencing strong growth, propelled by the expanding pipeline of therapies addressing oncology, rare diseases, and autoimmune conditions. Biosimilars are also a key driver, as patent expirations on blockbuster biologics fuel a wave of development and manufacturing partnerships. Both emerging biotech firms and global pharmaceutical leaders are increasingly turning to CMOs to achieve greater operational agility and capital efficiency. The COVID-19 pandemic further highlighted the importance of resilient, high-capacity networks, cementing CMOs as indispensable partners in global healthcare preparedness.
Technological advances, ranging from AI-driven process optimisation to continuous bioprocessing, are transforming efficiency and quality standards in outsourced production. At the same time, emerging markets such as India and China are becoming more integral to global supply chains, supported by cost competitiveness and improving regulatory frameworks. These dynamics are expanding the geographic footprint of contract manufacturing, diversifying risk, and opening new avenues for growth.
As demand for biologics and next-generation therapies accelerates, contract manufacturing will remain a cornerstone of the biopharmaceutical value chain. CMOs are evolving from capacity providers into strategic partners, offering innovation, resilience, and flexibility that are increasingly essential in a competitive and fast-changing global healthcare landscape.
What would be the Impact of US Trade Tariffs on the Global Biopharmaceuticals Contract Manufacturing Market?
The introduction of U.S. trade tariffs on pharmaceutical inputs, biologics, and specialised manufacturing equipment is creating new pressures for the global biopharmaceutical contract manufacturing market. By raising the cost of raw materials, reagents, and critical production tools, these measures are disrupting established cost structures and supply chains. Contract manufacturers that rely on cross-border sourcing or export to the United States are particularly exposed, facing higher operating costs, potential delays, and reduced margins-factors that could translate into increased pricing for sponsors and limit the affordability of biologics and biosimilars.
At the same time, tariffs are prompting a reassessment of global outsourcing strategies. Biopharmaceutical companies are moving to diversify suppliers, invest in localised production capacity, and channel outsourcing toward regions unaffected by tariffs. This shift is increasing interest in Southeast Asia, India, and selected European markets, where improving regulatory standards and competitive cost bases support expansion. While U.S.-based CMOs may benefit in the short term from stronger domestic demand, their ability to maintain this position will depend on policy clarity and the scale of infrastructure investment.
In effect, tariffs are acting as both a disruptor and a catalyst-raising immediate costs while driving structural changes in how and where manufacturing is conducted. For CMOs and their partners, the priority will be to adapt quickly, balancing short-term challenges with the longer-term opportunity to build more resilient and regionally diversified supply networks.
What Questions Should You Ask before Buying a Market Research Report?
- How is the biopharmaceuticals contract manufacturing market evolving?
- What is driving and restraining the biopharmaceuticals contract manufacturing market?
- How will each biopharmaceuticals contract manufacturing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
- How will the market shares for each biopharmaceuticals contract manufacturing submarket develop from 2025 to 2035?
- What will be the main driver for the overall market from 2025 to 2035?
- Will leading biopharmaceuticals contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
- Who are the leading players and what are their prospects over the forecast period?
- What are the biopharmaceuticals contract manufacturing projects for these leading companies?
- How will the industry evolve during the period between 2025 and 2035? What are the implications of
- biopharmaceuticals contract manufacturing projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the biopharmaceuticals contract manufacturing market?
- Where is the biopharmaceuticals contract manufacturing market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Biopharmaceuticals Contract Manufacturing market today, and over the next 10 years:
- Our 393-page report provides 138 tables and 174 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them - NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
- Forecasts to 2035 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.
Segments Covered in the Report
- Source
- Mammalian
- Non-mammalian
- Service
- Process Development
- Downstream
- Upstream
- Fill & Finish Operations
- Analytical & QC Studies
- Packaging
- Product
- Biologics
- Monoclonal Antibodies (mAbs)
- Recombinant Proteins
- Vaccines
- Others
- Biosimilars
- Company Size
- Small
- Mid-sized
- Large
- Scale of Operations
- Preclinical
- Clinical
- Commercial
- Therapeutic Area
- Oncology
- Autoimmune Diseases
- Cardiovascular Diseases
- Metabolic Diseases
- Infectious Diseases
- Neurology
- Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 26 leading national markets:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- MEA
- GCC
- South Africa
- Rest of MEA
The report also includes profiles for some of the leading companies in the Biopharmaceuticals Contract Manufacturing Market, 2025 to 2035, with a focus on this segment of these companies' operations.
- Leading companies and the potential for market growth
- AbbVie Inc.
- AGC Biologics
- Avantor, Inc.
- Binex Co., Ltd.
- Boehringer Ingelheim International GmbH
- Cambrex Corporation
- Catalent, Inc
- Curia Global, Inc.
- Cytiva
- FUJIFILM Diosynth Biotechnologies
- JRS PHARMA
- Jubilant Pharma Limited
- KBI Biopharma
- Lonza
- Pfizer CentreOne
- ProBioGen AG
- Rentschler Biopharma SE
- Samsung Biologics
- Sandoz Group AG
- TOYOBO CO., LTD.
- Thermo Fisher Scientific Inc.
- WuXi Biologics
Overall world revenue for Biopharmaceuticals Contract Manufacturing Market, 2025 to 2035 in terms of value the market will surpass US$17.0 billion in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
- How will the Biopharmaceuticals Contract Manufacturing Market, 2025 to 2035 report help you?
- In summary, our 390+ page report provides you with the following knowledge:
- Revenue forecasts to 2035 for Biopharmaceuticals Contract Manufacturing Market 2025 to 2035, with forecasts for source, service, product, company size, and scale of operations, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2035 for five regional and 26 key national markets - See forecasts for the Biopharmaceuticals Contract Manufacturing Market, 2025 to 2035 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 22 of the major companies involved in the Biopharmaceuticals Contract Manufacturing Market, 2025 to 2035.
- Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Product Code: PHA1372
Table of Contents
1 Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Biopharmaceuticals Contract Manufacturing Market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report Include:
- 1.6 Who is This Report For?
- 1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.7.3.1 Primary Research
- 1.7.3.2 Secondary Research
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Visiongain Reports
- 1.10 About Visiongain
2 Executive Summary
3 Market Overview
- 3.1 Key Findings
- 3.2 Market Dynamics
- 3.3 Impact Analysis
- 3.3.1 Market Driving Factors
- 3.3.1.1 Rise in Investment by CMOs for Capacity Expansion
- 3.3.1.2 Cost and Time Saving Benefits Offered by Contract Services
- 3.3.1.3 Outsourcing Boosting the Market Growth
- 3.3.1.4 Growing Investments in Orphan Drugs
- 3.3.2 Market Restraining Factors
- 3.3.2.1 Pricing Pressure to Impede Market Growth
- 3.3.2.2 Stringent Regulatory Scenarios
- 3.3.2.3 Overcapacity Projected to Challenge Market Growth
- 3.3.3 Market Opportunities
- 3.3.3.1 Expansion of Fill and Finish CMOs
- 3.3.3.2 Emergence of Single-Use Bioprocessing Equipment & Solutions
- 3.3.3.3 Emerging Economies to Offer Lucrative Growth Opportunities
- 3.3.1 Market Driving Factors
- 3.4 U.S. Tariffs: What's the Impact on Global Biopharmaceuticals Contract Manufacturing Market?
- 3.4.1 Overview
- 3.4.2 V-Shaped Recovery Scenario
- 3.4.3 Why V-Shaped Recovery?
- 3.4.3.1 Impact from Tariffs
- 3.4.3.2 Market Dynamics and Demand Recovery
- 3.4.3.3 Policy and Funding Support
- 3.4.3.4 Timeframe for Recovery
- 3.4.4 U-Shaped Recovery Scenario
- 3.4.4.1 Why U-Shaped Recovery?
- 3.4.4.2 Impact from Tariffs
- 3.4.4.3 Market Dynamics and Demand Recovery
- 3.4.4.4 Policy and Funding Support
- 3.4.4.5 Timeframe for Recovery
- 3.4.5 L Shaped Recovery Scenario
- 3.4.5.1 Why L-Shaped Recovery?
- 3.4.5.2 Impact from Tariffs
- 3.4.5.3 Market Dynamics and Demand Recovery
- 3.4.5.4 Policy and Funding Support
- 3.4.5.5 Timeframe for Recovery
- 3.4.6 What Strategic Considerations Should Clients Factor into Their Near-term (2025-2030) and Long-term (2025-2035) Planning?
- 3.4.7 Impact of U.S. and China Trade War on Biopharmaceuticals Contract Manufacturing Market
- 3.4.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
- 3.5 Porter's Five Forces Analysis
- 3.5.1 Bargaining Power of Buyers
- 3.5.2 Bargaining Power of Suppliers
- 3.5.3 Competitive Rivalry
- 3.5.4 Threat of Substitutes
- 3.5.5 Threat of New Entrants
- 3.6 PEST Analysis
- 3.6.1 Political Factors Impacting Biopharmaceuticals Contract Manufacturing Market
- 3.6.2 Economic Factors Impacting Biopharmaceuticals Contract Manufacturing Market
- 3.6.3 Social Factors Impacting Biopharmaceuticals Contract Manufacturing Market
- 3.6.4 Technological Factors Impacting Biopharmaceuticals Contract Manufacturing Market
4 Biopharmaceuticals Contract Manufacturing Market Analysis by Source
- 4.1 Key Findings
- 4.2 Source Segment: Market Attractiveness Index
- 4.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
- 4.4 Mammalian
- 4.4.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 4.4.2 Market Share by Region, 2025 & 2035 (%)
- 4.5 Non-mammalian
- 4.5.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 4.5.2 Market Share by Region, 2025 & 2035 (%)
5 Biopharmaceuticals Contract Manufacturing Market Analysis by Service
- 5.1 Key Findings
- 5.2 Service Segment: Market Attractiveness Index
- 5.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
- 5.4 Process Development
- 5.4.1 Process Development Market Size Estimation and Forecast by Type
- 5.4.2 Upstream Process Development
- 5.4.3 Downstream Process Development
- 5.4.4 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 5.4.5 Market Share by Region, 2025 & 2035 (%)
- 5.5 Fill & Finish Operations
- 5.5.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 5.5.2 Market Share by Region, 2025 & 2035 (%)
- 5.6 Analytical & QC Studies
- 5.6.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 5.6.2 Market Share by Region, 2025 & 2035 (%)
- 5.7 Packaging
- 5.7.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 5.7.2 Market Share by Region, 2025 & 2035 (%)
6 Biopharmaceuticals Contract Manufacturing Market Analysis by Product
- 6.1 Key Findings
- 6.2 Product Segment: Market Attractiveness Index
- 6.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
- 6.4 Biologics
- 6.4.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 6.4.2 Market Share by Region, 2025 & 2035 (%)
- 6.4.3 Biologics Market Size Estimation and Forecast by Type
- 6.4.3.1 Monoclonal Antibodies (mAbs)
- 6.4.3.2 Recombinant Proteins
- 6.4.3.3 Vaccines
- 6.4.3.4 Others
- 6.5 Biosimilars
- 6.5.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 6.5.2 Market Share by Region, 2025 & 2035 (%)
7 Biopharmaceuticals Contract Manufacturing Market Analysis by Company Size
- 7.1 Key Findings
- 7.2 Company Size Segment: Market Attractiveness Index
- 7.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
- 7.4 Small
- 7.4.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 7.4.2 Market Share by Region, 2025 & 2035 (%)
- 7.5 Mid-sized
- 7.5.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 7.5.2 Market Share by Region, 2025 & 2035 (%)
- 7.6 Large
- 7.6.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 7.6.2 Market Share by Region, 2025 & 2035 (%)
8 Biopharmaceuticals Contract Manufacturing Market Analysis by Scale of Operations
- 8.1 Key Findings
- 8.2 Scale of Operations Segment: Market Attractiveness Index
- 8.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
- 8.4 Preclinical
- 8.4.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 8.4.2 Market Share by Region, 2025 & 2035 (%)
- 8.5 Clinical
- 8.5.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 8.5.2 Market Share by Region, 2025 & 2035 (%)
- 8.6 Commercial
- 8.6.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 8.6.2 Market Share by Region, 2025 & 2035 (%)
9 Biopharmaceuticals Contract Manufacturing Market Analysis by Therapeutic Area
- 9.1 Key Findings
- 9.2 Therapeutic Area Segment: Market Attractiveness Index
- 9.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
- 9.4 Oncology
- 9.4.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 9.4.2 Market Share by Region, 2025 & 2035 (%)
- 9.5 Autoimmune Diseases
- 9.5.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 9.5.2 Market Share by Region, 2025 & 2035 (%)
- 9.6 Cardiovascular Diseases
- 9.6.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 9.6.2 Market Share by Region, 2025 & 2035 (%)
- 9.7 Metabolic Diseases
- 9.7.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 9.7.2 Market Share by Region, 2025 & 2035 (%)
- 9.8 Infectious Diseases
- 9.8.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 9.8.2 Market Share by Region, 2025 & 2035 (%)
- 9.9 Neurology
- 9.9.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 9.9.2 Market Share by Region, 2025 & 2035 (%)
- 9.10 Others
- 9.10.1 Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- 9.10.2 Market Share by Region, 2025 & 2035 (%)
10 Biopharmaceuticals Contract Manufacturing Market Analysis by Region
- 10.1 Key Findings
- 10.2 Regional Market Size Estimation and Forecast
11 North America Biopharmaceuticals Contract Manufacturing Market Analysis
- 11.1 Key Findings
- 11.2 North America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
- 11.3 North America Biopharmaceuticals Contract Manufacturing Market by Country, 2025, 2030 & 2035 (US$ Million)
- 11.4 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
- 11.5 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
- 11.6 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
- 11.7 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
- 11.8 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
- 11.9 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
- 11.10 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
- 11.11 U.S. Biopharmaceuticals Contract Manufacturing Market Analysis
- 11.12 Canada Biopharmaceuticals Contract Manufacturing Market Analysis
12 Europe Biopharmaceuticals Contract Manufacturing Market Analysis
- 12.1 Key Findings
- 12.2 Europe Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
- 12.3 Europe Biopharmaceuticals Contract Manufacturing Market by Country, 2025, 2030 & 2035 (US$ Million)
- 12.4 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
- 12.5 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
- 12.6 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
- 12.7 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
- 12.8 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
- 12.9 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
- 12.10 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
- 12.11 Germany Biopharmaceuticals Contract Manufacturing Market Analysis
- 12.12 UK Biopharmaceuticals Contract Manufacturing Market Analysis
- 12.13 France Biopharmaceuticals Contract Manufacturing Market Analysis
- 12.14 Italy Biopharmaceuticals Contract Manufacturing Market Analysis
- 12.15 Spain Biopharmaceuticals Contract Manufacturing Market Analysis
- 12.16 Russia Biopharmaceuticals Contract Manufacturing Market Analysis
- 12.17 Netherlands Biopharmaceuticals Contract Manufacturing Market Analysis
- 12.18 Switzerland Biopharmaceuticals Contract Manufacturing Market Analysis
- 12.19 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Analysis
13 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Analysis
- 13.1 Key Findings
- 13.2 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
- 13.3 Asia Pacific Biopharmaceuticals Contract Manufacturing Market by Country, 2025, 2030 & 2035 (US$ Million)
- 13.4 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
- 13.5 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
- 13.6 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
- 13.7 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
- 13.8 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
- 13.9 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
- 13.10 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
- 13.11 Japan Biopharmaceuticals Contract Manufacturing Market Analysis
- 13.12 China Biopharmaceuticals Contract Manufacturing Market Analysis
- 13.13 India Biopharmaceuticals Contract Manufacturing Market Analysis
- 13.14 Australia Biopharmaceuticals Contract Manufacturing Market Analysis
- 13.15 South Korea Biopharmaceuticals Contract Manufacturing Market Analysis
- 13.16 South-East Asia Biopharmaceuticals Contract Manufacturing Market Analysis
- 13.17 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Analysis
14 Latin America Biopharmaceuticals Contract Manufacturing Market Analysis
- 14.1 Key Findings
- 14.2 Latin America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
- 14.3 Latin America Biopharmaceuticals Contract Manufacturing Market by Country, 2025, 2030 & 2035 (US$ Million)
- 14.4 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
- 14.5 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
- 14.6 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
- 14.7 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
- 14.8 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
- 14.9 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
- 14.10 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
- 14.11 Brazil Biopharmaceuticals Contract Manufacturing Market Analysis
- 14.12 Mexico Biopharmaceuticals Contract Manufacturing Market Analysis
- 14.13 Argentina Biopharmaceuticals Contract Manufacturing Market Analysis
- 14.14 Colombia Biopharmaceuticals Contract Manufacturing Market Analysis
- 14.15 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Analysis
15 MEA Biopharmaceuticals Contract Manufacturing Market Analysis
- 15.1 Key Findings
- 15.2 MEA Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
- 15.3 MEA Biopharmaceuticals Contract Manufacturing Market by Country, 2025, 2030 & 2035 (US$ Million)
- 15.4 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
- 15.5 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
- 15.6 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
- 15.7 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
- 15.8 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
- 15.9 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
- 15.10 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
- 15.11 GCC Biopharmaceuticals Contract Manufacturing Market Analysis
- 15.12 South Africa Biopharmaceuticals Contract Manufacturing Market Analysis
- 15.13 Rest of MEA Biopharmaceuticals Contract Manufacturing Market Analysis
16 Company Profiles
- 16.1 AbbVie, Inc.
- 16.1.1 Company Snapshot
- 16.1.2 Company Overview
- 16.1.3 Financial Analysis
- 16.1.3.1 Net Revenue, 2020-2024
- 16.1.3.2 R&D Expenses, 2020-2024
- 16.1.3.3 Regional Market Shares, 2024
- 16.1.3.4 Business Segment Market Shares, 2024
- 16.1.4 Service Benchmarking
- 16.2 AGC Biologics
- 16.2.1 Company Snapshot
- 16.2.2 Company Overview
- 16.2.3 Service Benchmarking
- 16.2.4 Strategic Outlook
- 16.3 Avantor, Inc.
- 16.3.1 Company Snapshot
- 16.3.2 Company Overview
- 16.3.3 Financial Analysis
- 16.3.3.1 Net Revenue, 2020-2024
- 16.3.3.2 Business Segment Market Shares, 2024
- 16.3.4 Service Benchmarking
- 16.3.5 Strategic Outlook
- 16.4 Binex Co., Ltd.
- 16.4.1 Company Snapshot
- 16.4.2 Company Overview
- 16.4.3 Service Benchmarking
- 16.5 Boehringer Ingelheim GmbH
- 16.5.1 Company Snapshot
- 16.5.2 Company Overview
- 16.5.3 Financial Analysis
- 16.5.3.1 Net Revenue, 2020-2024
- 16.5.4 Service Benchmarking
- 16.6 FUJIFILM Diosynth Biotechnologies
- 16.6.1 Company Snapshot
- 16.6.2 Company Overview
- 16.6.3 Service Benchmarking
- 16.6.4 Strategic Outlook
- 16.7 Lonza
- 16.7.1 Company Snapshot
- 16.7.2 Company Overview
- 16.7.3 Financial Analysis
- 16.7.3.1 Net Revenue, 2020-2024
- 16.7.3.2 R&D Expenses, 2018-2022
- 16.7.4 Service Benchmarking
- 16.7.5 Strategic Outlook
- 16.8 ProBioGen
- 16.8.1 Company Snapshot
- 16.8.2 Company Overview
- 16.8.3 Service Benchmarking
- 16.8.4 Strategic Outlook
- 16.9 Rentschler Biopharma SE
- 16.9.1 Company Snapshot
- 16.9.2 Company Overview
- 16.9.3 Service Benchmarking
- 16.9.4 Strategic Outlook
- 16.10 Samsung Biologics
- 16.10.1 Company Snapshot
- 16.10.2 Company Overview
- 16.10.3 Service Benchmarking
- 16.10.4 Strategic Outlook
- 16.11 Sandoz
- 16.11.1 Company Snapshot
- 16.11.2 Company Overview
- 16.11.3 Financial Analysis
- 16.11.3.1 Net Revenue, 2020-2024
- 16.11.3.2 Regional Market Shares, 2024
- 16.11.4 Service Benchmarking
- 16.11.5 Strategic Outlook
- 16.12 TOYOBO CO., LTD.
- 16.12.1 Company Snapshot
- 16.12.2 Company Overview
- 16.12.3 Service Benchmarking
- 16.13 WuXi Biologics
- 16.13.1 Company Snapshot
- 16.13.2 Company Overview
- 16.13.3 Financial Analysis
- 16.13.3.1 Net Revenue, 2020-2024
- 16.13.3.2 Regional Market Shares, 2024
- 16.13.3.3 Business Segment Market Shares, 2024
- 16.13.4 Service Benchmarking
- 16.13.5 Strategic Outlook
- 16.14 JRS PHARMA
- 16.14.1 Company Snapshot
- 16.14.2 Company Overview
- 16.14.3 Service Benchmarking
- 16.15 Thermo Fisher Scientific
- 16.15.1 Company Snapshot
- 16.15.2 Company Overview
- 16.15.3 Financial Analysis
- 16.15.3.1 Net Revenue, 2020-2024
- 16.15.3.2 R&D, 2020-2024
- 16.15.3.3 Regional Market Shares, 2024
- 16.15.3.4 Business Segment Market Shares, 2024
- 16.15.4 Service Benchmarking
- 16.16 Cambrex Corporation
- 16.16.1 Company Snapshot
- 16.16.2 Company Overview
- 16.16.3 Service Benchmarking
- 16.16.4 Strategic Outlook
- 16.17 Curia Global, Inc.
- 16.17.1 Company Snapshot
- 16.17.2 Company Overview
- 16.17.3 Service Benchmarking
- 16.17.4 Strategic Outlook
- 16.18 Pfizer CentreOne
- 16.18.1 Company Snapshot
- 16.18.2 Company Overview
- 16.18.3 Financial Analysis
- 16.18.3.1 Net Revenue, 2020-2024
- 16.18.3.2 R&D, 2020-2024
- 16.18.3.3 Regional Market Shares, 2024
- 16.18.3.4 Business Segment Market Shares, 2024
- 16.18.4 Service Benchmarking
- 16.19 Jubilant Pharma Limited
- 16.19.1 Company Snapshot
- 16.19.2 Company Overview
- 16.19.3 Service Benchmarking
- 16.20 Catalent, Inc. (Novo Holdings)
- 16.20.1 Company Snapshot
- 16.20.2 Company Overview
- 16.20.3 Financial Analysis
- 16.20.3.1 Net Revenue, 2020-2024
- 16.20.4 Service Benchmarking
- 16.20.5 Strategic Outlook
- 16.21 KBI Biopharma
- 16.21.1 Company Snapshot
- 16.21.2 Company Overview
- 16.21.3 Service Benchmarking
- 16.21.4 Strategic Outlook
- 16.22 Cytiva
- 16.22.1 Company Snapshot
- 16.22.2 Company Overview
- 16.22.3 Service Benchmarking
- 16.22.4 Strategic Outlook
17 Conclusion and Recommendations
- 17.1 Concluding Remarks from Visiongain
- 17.2 Recommendations for Market Players
Product Code: PHA1372
List of Tables
- Table 1 Biopharmaceuticals Contract Manufacturing Market Snapshot, 2025 & 2035 (US$ million, CAGR %)
- Table 2 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2025-2035 (US$ Mn, AGR %, CAGR %): "V" Shaped Recovery
- Table 3 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2025-2035 (US$ Mn, AGR %, CAGR %): "U" Shaped Recovery
- Table 4 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2025-2035 (US$ Mn, AGR %, CAGR %): "L" Shaped Recovery
- Table 5 Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 6 Mammalian Segment Market Forecast by Region, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 7 Non-mammalian Segment Market Forecast by Region, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 8 Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 9 Process Development Segment Market Forecast by Region, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 10 Fill & Finish Operations Segment Market Forecast by Region, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 11 Analytical & QC Studies Segment Market Forecast by Region, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 12 Packaging Segment Market Forecast by Region, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 13 Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 14 Biologics Segment Market Forecast by Region, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 15 Biopharmaceuticals Contract Manufacturing Market Forecast by Application, 2025-2035 (US$ mn, AGR%, CAGR%)
- Table 16 Biosimilars Segment Market Forecast by Region, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 17 Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 18 Small Segment Market Forecast by Region, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 19 Mid-sized Segment Market Forecast by Region, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 20 Large Segment Market Forecast by Region, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 21 Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 22 Preclinical Segment Market Forecast by Region, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 23 Clinical Segment Market Forecast by Region, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 24 Commercial Segment Market Forecast by Region, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 25 Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2025-2035 (US$ mn, AGR%, CAGR%)
- Table 26 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 27 Autoimmune Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 28 Cardiovascular Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 29 Metabolic Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 30 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 31 Neurology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 32 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 33 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 34 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 35 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 36 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 37 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 38 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 39 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 40 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2025-2035 (US$ mn, AGR%, CAGR%)
- Table 41 U.S. Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 42 Canada Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 43 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 44 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 45 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 46 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 47 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 48 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 49 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2025-2035 (US$ mn, AGR%, CAGR%)
- Table 50 Germany Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 51 UK Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 52 France Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 53 Italy Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 54 Spain Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 55 Russia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 56 Netherlands Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 57 Switzerland Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 58 Rest of Europe Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 59 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 60 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 61 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 62 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 63 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 64 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 65 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2025-2035 (US$ mn, AGR%, CAGR%)
- Table 66 Japan Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 67 China Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 68 India Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 69 Australia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 70 South Korea Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 71 South-East Asia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 72 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 73 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 74 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 75 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 76 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 77 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 78 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 79 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2025-2035 (US$ mn, AGR%, CAGR%)
- Table 80 Brazil Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 81 Mexico Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 82 Argentina Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 83 Colombia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 84 Rest of Latin America Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 85 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 86 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 87 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 88 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 89 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 90 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Mn, AGR %, CAGR %)
- Table 91 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2025-2035 (US$ mn, AGR%, CAGR%)
- Table 92 GCC Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 93 South Africa Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 94 Rest of MEA Biopharmaceuticals Contract Manufacturing) Market Forecast, 2025-2035 (US$ Million, AGR %, CAGR %)
- Table 95 AbbVie, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 96 AbbVie, Inc.: Service Benchmarking
- Table 97 AGC Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 98 AGC Biologics: Service Benchmarking
- Table 99 AGC Biologics: Strategic Outlook
- Table 100 Avantor, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 101 Avantor, Inc.: Service Benchmarking
- Table 102 Avantor, Inc.: Strategic Outlook
- Table 103 Binex Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 104 Binex Co., Ltd.: Service Benchmarking
- Table 105 Boehringer Ingelheim GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 106 Boehringer Ingelheim GmbH: Service Benchmarking
- Table 107 FUJIFILM Diosynth Biotechnologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 108 FUJIFILM Diosynth Biotechnologies: Service Benchmarking
- Table 109 FUJIFILM Diosynth Biotechnologies: Strategic Outlook
- Table 110 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 111 Lonza: Service Benchmarking
- Table 112 Lonza: Strategic Outlook
- Table 113 ProBioGen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 114 ProBioGen: Service Benchmarking
- Table 115 ProBioGen: Strategic Outlook
- Table 116 Rentschler Biopharma SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 117 Rentschler Biopharma SE: Service Benchmarking
- Table 118 Rentschler Biopharma SE: Strategic Outlook
- Table 119 Samsung Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 120 Samsung Biologics: Service Benchmarking
- Table 121 Samsung Biologics: Strategic Outlook
- Table 122 Sandoz: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 123 Sandoz: Service Benchmarking
- Table 124 Sandoz: Strategic Outlook
- Table 125 TOYOBO CO., LTD.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 126 TOYOBO CO., LTD.: Service Benchmarking
- Table 127 WuXi Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 128 WuXi Biologics: Service Benchmarking
- Table 129 WuXi Biologics: Strategic Outlook
- Table 130 JRS PHARMA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 131 JRS PHARMA: Service Benchmarking
- Table 132 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 133 Thermo Fisher Scientific: Service Benchmarking
- Table 134 Cambrex Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 135 Cambrex Corporation: Service Benchmarking
- Table 136 Cambrex Corporation: Strategic Outlook
- Table 137 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 138 Curia Global, Inc.: Service Benchmarking
- Table 139 Curia Global, Inc.: Strategic Outlook
- Table 140 Pfizer CentreOne: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 141 Pfizer CentreOne: Service Benchmarking
- Table 142 Jubilant Pharma Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 143 Jubilant Pharma Limited: Service Benchmarking
- Table 144 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 145 Catalent, Inc: Service Benchmarking
- Table 146 Catalent, Inc: Strategic Outlook
- Table 147 KBI Biopharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 148 KBI Biopharma: Service Benchmarking
- Table 149 KBI Biopharma: Strategic Outlook
- Table 150 Cytiva: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 151 Cytiva: Service Benchmarking
- Table 152 Cytiva: Strategic Outlook
List of Figures
- Figure 1 Biopharmaceuticals Contract Manufacturing Market Segmentation
- Figure 2 Biopharmaceuticals Contract Manufacturing Market by Source: Market Attractiveness Index
- Figure 3 Biopharmaceuticals Contract Manufacturing Market by Service: Market Attractiveness Index
- Figure 4 Biopharmaceuticals Contract Manufacturing Market by Product: Market Attractiveness Index
- Figure 5 Biopharmaceuticals Contract Manufacturing Market by Company Size: Market Attractiveness Index
- Figure 6 Biopharmaceuticals Contract Manufacturing Market by Scale of Operations: Market Attractiveness Index
- Figure 7 Biopharmaceuticals Contract Manufacturing Market by Therapeutic Area: Market Attractiveness Index
- Figure 8 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Region
- Figure 9 Biopharmaceuticals Contract Manufacturing Market: Market Dynamics
- Figure 10 Biopharmaceuticals Contract Manufacturing Market: Impact Analysis
- Figure 11 Biopharmaceuticals Contract Manufacturing Market by Region, 2025-2035 (US$ Million, AGR %), Tariff Impact: V-Shaped Recovery Scenario
- Figure 12 Biopharmaceuticals Contract Manufacturing Market by Region, 2025-2035 (US$ Million, AGR %), Tariff Impact: U-Shaped Recovery Scenario
- Figure 13 Biopharmaceuticals Contract Manufacturing Market by Region, 2025-2035 (US$ Million, AGR %), Tariff Impact: L-Shaped Recovery Scenario
- Figure 14 Short Term & Long Term Planning
- Figure 15 Impact of U.S. and China Trade War
- Figure 16 Most Impacted Countries
- Figure 17 SWOT Analysis
- Figure 18 Porter's Five Forces Analysis
- Figure 19 PEST Analysis
- Figure 20 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Source
- Figure 21 Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Million, AGR %)
- Figure 22 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2025, 2030 & 2035 (%)
- Figure 23 Mammalian Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 24 Mammalian Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 25 Non-mammalian Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 26 Non-mammalian Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 27 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Source
- Figure 28 Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Million, AGR %)
- Figure 29 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2025, 2030 & 2035 (%)
- Figure 30 Process Development Market Forecast by Type, 2025-2035 (US$ Million, AGR %)
- Figure 31 Process Development Market by Type, 2025, 2030 & 2035 (%)
- Figure 32 Process Development Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 33 Process Development Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 34 Fill & Finish Operations Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 35 Fill & Finish Operations Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 36 Analytical & QC Studies Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 37 Analytical & QC Studies Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 38 Packaging Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 39 Packaging Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 40 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Product
- Figure 41 Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Million, AGR %)
- Figure 42 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2025, 2030 & 2035 (%)
- Figure 43 Biologics Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 44 Biologics Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 45 Biologics Market Forecast by Type, 2025-2035 (US$ Million, AGR %)
- Figure 46 Biologics Market by Type, 2025, 2030 & 2035 (%)
- Figure 47 Biosimilars Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 48 Biosimilars Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 49 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Company Size
- Figure 50 Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Million, AGR %)
- Figure 51 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2025, 2030 & 2035 (%)
- Figure 52 Small Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 53 Small Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 54 Mid-sized Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 55 Mid-sized Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 56 Large Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 57 Large Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 58 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Scale of Operations
- Figure 59 Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2025-2035 (US$ Million, AGR %)
- Figure 60 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2025, 2030 & 2035 (%)
- Figure 61 Preclinical Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 62 Preclinical Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 63 Clinical Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 64 Clinical Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 65 Commercial Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 66 Commercial Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 67 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Therapeutic Area
- Figure 68 Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
- Figure 69 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2025, 2030 & 2035 (%)
- Figure 70 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 71 Oncology Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 72 Autoimmune Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 73 Autoimmune Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 74 Cardiovascular Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 75 Cardiovascular Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 76 Metabolic Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 77 Metabolic Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 78 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 79 Infectious Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 80 Neurology Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 81 Neurology Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 82 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
- Figure 83 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 84 Biopharmaceuticals Contract Manufacturing Market Forecast by Region 2025, 2030 & 2035 (Revenue, CAGR%)
- Figure 85 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Region 2025, 2030 & 2035 (%)
- Figure 86 Biopharmaceuticals Contract Manufacturing Market by Region, 2025-2035 (US$ Mn)
- Figure 87 North America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
- Figure 88 North America Biopharmaceuticals Contract Manufacturing Market by Region, 2025, 2030 & 2035 (US$ Million)
- Figure 89 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
- Figure 90 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2025 & 2035 (%)
- Figure 91 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Million, AGR %)
- Figure 92 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2025 & 2035 (%)
- Figure 93 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Million, AGR %)
- Figure 94 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2025 & 2035 (%)
- Figure 95 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Million, AGR %)
- Figure 96 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2025 & 2035 (%)
- Figure 97 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Million, AGR %)
- Figure 98 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2025 & 2035 (%)
- Figure 99 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2025-2035 (US$ Million, AGR %)
- Figure 100 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2025 & 2035 (%)
- Figure 101 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
- Figure 102 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
- Figure 103 U.S. Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 104 Canada Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 105 Europe Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
- Figure 106 Europe Biopharmaceuticals Contract Manufacturing Market by Region, 2025, 2030 & 2035 (US$ Million)
- Figure 107 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
- Figure 108 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2025 & 2035 (%)
- Figure 109 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Million, AGR %)
- Figure 110 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2025 & 2035 (%)
- Figure 111 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Million, AGR %)
- Figure 112 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2025 & 2035 (%)
- Figure 113 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Million, AGR %)
- Figure 114 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2025 & 2035 (%)
- Figure 115 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Million, AGR %)
- Figure 116 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2025 & 2035 (%)
- Figure 117 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2025-2035 (US$ Million, AGR %)
- Figure 118 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2025 & 2035 (%)
- Figure 119 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
- Figure 120 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
- Figure 121 Germany Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 122 UK Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 123 France Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 124 Italy Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 125 Spain Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 126 Russia Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 127 Netherlands Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 128 Switzerland Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 129 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 130 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
- Figure 131 Asia Pacific Biopharmaceuticals Contract Manufacturing Market by Region, 2025, 2030 & 2035 (US$ Million)
- Figure 132 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
- Figure 133 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2025 & 2035 (%)
- Figure 134 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Million, AGR %)
- Figure 135 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2025 & 2035 (%)
- Figure 136 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Million, AGR %)
- Figure 137 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2025 & 2035 (%)
- Figure 138 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Million, AGR %)
- Figure 139 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2025 & 2035 (%)
- Figure 140 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Million, AGR %)
- Figure 141 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2025 & 2035 (%)
- Figure 142 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2025-2035 (US$ Million, AGR %)
- Figure 143 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2025 & 2035 (%)
- Figure 144 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
- Figure 145 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
- Figure 146 Japan Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 147 China Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 148 India Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 149 Australia Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 150 South Korea Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 151 South-East Asia Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 152 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 153 Latin America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
- Figure 154 Latin America Biopharmaceuticals Contract Manufacturing Market by Region, 2025, 2030 & 2035 (US$ Million)
- Figure 155 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
- Figure 156 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2025 & 2035 (%)
- Figure 157 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Million, AGR %)
- Figure 158 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2025 & 2035 (%)
- Figure 159 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Million, AGR %)
- Figure 160 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2025 & 2035 (%)
- Figure 161 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Million, AGR %)
- Figure 162 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2025 & 2035 (%)
- Figure 163 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Million, AGR %)
- Figure 164 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2025 & 2035 (%)
- Figure 165 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2025-2035 (US$ Million, AGR %)
- Figure 166 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2025 & 2035 (%)
- Figure 167 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
- Figure 168 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
- Figure 169 Brazil Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 170 Mexico Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 171 Argentina Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 172 Colombia Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 173 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 174 MEA Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
- Figure 175 MEA Biopharmaceuticals Contract Manufacturing Market by Region, 2025, 2030 & 2035 (US$ Million)
- Figure 176 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
- Figure 177 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2025 & 2035 (%)
- Figure 178 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2025-2035 (US$ Million, AGR %)
- Figure 179 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2025 & 2035 (%)
- Figure 180 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2025-2035 (US$ Million, AGR %)
- Figure 181 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2025 & 2035 (%)
- Figure 182 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2025-2035 (US$ Million, AGR %)
- Figure 183 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2025 & 2035 (%)
- Figure 184 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2025-2035 (US$ Million, AGR %)
- Figure 185 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2025 & 2035 (%)
- Figure 186 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2025-2035 (US$ Million, AGR %)
- Figure 187 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2025 & 2035 (%)
- Figure 188 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
- Figure 189 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
- Figure 190 GCC Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 191 South Africa Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 192 Rest of MEA Biopharmaceuticals Contract Manufacturing Market Forecast, 2025-2035 (US$ Million, AGR %)
- Figure 193 AbbVie, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
- Figure 194 AbbVie, Inc.: R&D Expenses, 2020-2024 (US$ Million, AGR %)
- Figure 195 AbbVie, Inc.: Regional Market Shares, 2024(%)
- Figure 196 AbbVie, Inc.: Business Segment Market Shares, 2024(%)
- Figure 197 Avantor, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
- Figure 198 Avantor, Inc.: Business Segment Market Share (%)
- Figure 199 Boehringer Ingelheim GmbH: Net Revenue, 2020-2024 (US$ Million, AGR %)
- Figure 200 Lonza: Net Revenue, 2020-2024 (US$ Million, AGR %)
- Figure 201 Lonza: R&D Expenses, 2018-2022 (US$ Million, AGR %)
- Figure 202 Sandoz: Net Revenue, 2020-2024 (US$ Million, AGR %)
- Figure 203 Sandoz: Regional Market Share (%), 2024
- Figure 204 WuXi Biologics: Net Revenue, 2020-2024 (US$ Million, AGR %)
- Figure 205 WuXi Biologics: Regional Market Shares, 2024 (%)
- Figure 206 WuXi Biologics: Business Segment Market Shares, 2024 (%)
- Figure 207 Thermo Fisher Scientific: Net Revenue, 2020-2024 (US$ Million, AGR %)
- Figure 208 Thermo Fisher Scientific: R&D, 2020-2024 (US$ Million, AGR %)
- Figure 209 Thermo Fisher Scientific: Regional Market Shares, 2024 (%)
- Figure 210 Thermo Fisher Scientific: Business Segment Market Shares, 2024 (%)
- Figure 211 Pfizer CentreOne: Net Revenue, 2020-2024 (US$ Million, AGR %)
- Figure 212 Pfizer CentreOne: R&D, 2020-2024 (US$ Million, AGR %)
- Figure 213 Pfizer CentreOne: Regional Market Shares, 2024 (%)
- Figure 214 Pfizer CentreOne: Business Segment Market Shares, 2024 (%)
- Figure 215 Catalent, Inc: Net Revenue, 2020-2024 (US$ Million, AGR %)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.